FDA Investigator Lori B Wikstrom

Lori B Wikstrom has conducted inspections on 26 sites in 4 countries as of 05 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
26
Last Inspection Date:
05 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Spain, France, Mexico
FDA Investigators that have inspected at least one site in common with Lori B Wikstrom:
Aaron L Dunbar, Aerial A Smith, Alecia L Marson, Anders W Evenson, Anthony J Ladner, April L Young, Bei Y He, Benjamin W Anderson, Billi Jom Johnson, Brian L Szcyubialka, Bruce H Mccullough, Carl A Huffman, III, Charles L Zhou, Charles R Cote, RIC, Christina A Miller, Constance L Richard, Darrah, Debra I Love, Denise L Burosh, Dennis Cantellops Paite, Diane T Reindl, Erika V Butler, Gregory A Berg, Gregory R Brinsley, Gregory W Smith, Gwyn G Dickinson, Ivan E Reyes, Jacob W Reynolds, James I Giefer, James K Ireland, Jamie R Thompson, Janis R Armedoriz, Jasjeet K Sekhon, Jee Chung, PhD, Jeffry A Bernhardt, Jennifer A D'angelo, Jocelyn M Muggli, Joel D Hustedt, Jonathan R Campos, Jose Acruz Gonzalez, Joseph M Edwin, Juan Rjimenez Garcia, Junho Pak, Justin A Boyd, Kathleen A Schelble, Kathleen S Tormey, Kent C Faul, Kevin P Regan, Krishna Ghosh, PhD, Kyle J Mccracken, Leon R Stratman, Lloyd D Payne, Lori Wikstrom, Luis A Carrion, Marie A Fadden, Marie F Morin, Marissa S Steinhagen, Matthew B Casale, Matthew M Schuckmann, Melanie C Voges, Melissa M Steiger, Michael A Charles, Natalie E Starczowski, Nibin Varghese, MS, Nicholas J Dubrovin, Nikki S Bryant, Paul L Bellamy, Peter T Erlandson, Rafael Nevarez Nieves, Ralph Jerndal, Robert M Barbosa, Ronald R Ruff, Ross J Grigsby, Sandra A Boyd, Sandra A Hughes, Sandra D Wilson, Scott T Ballard, Stefanie L Heckman, Steven D Kehoe, Susan M Matthias, Suzanne N Vallez, Suzanne Vallez, Taichun Qin, PhD, Tenzin Jangchup, Tiara Nbrown Crosen, Tiffani D Wilson, Tony T Yang, Tyler M Peterson, Vaishali J Patel, Victoria A Wagoner, Yehualashet A Gessesse, Ying Xin Fan, PhD

Lori B Wikstrom's Documents

Publish Date Document Type Title
March, 2020 FDA 483 Kendrick Laboratories, Inc. - Form 483, 2020-03-10
October, 2021 FDA 483 Kingchem Laboratories Inc. - Form 483, 2021-10-22
September, 2022 FDA 483 MBB Production Mexico S. de R.L. de C.V. - Form 483, 2022-09-29
July, 2022 FDA 483 Topical Pharmaceuticals Inc. - Form 483, 2022-07-01
September, 2022 FDA 483 Fersinsa GB, S.A. de C.V. - Form 483, 2022-09-23
January, 2023 FDA 483 Nexus Pharmaceuticals, LLC - Form 483, 2023-01-20
September, 2023 FDA 483 Isomedix Operations Inc - Form 483, 2023-09-15
November, 2023 FDA 483 Ajinomoto Health & Nutrition North America Inc - Form 483, 2023-11-20
July, 2023 FDA 483 Kaysersberg Pharmaceuticals - Form 483, 2023-07-07
April, 2023 FDA 483 Wisconsin Medical Radiopharmacy, LLC - Form 483, 2023-04-17
September, 2023 FDA 483 University of Wisconsin Radiopharmaceutical Production Facility - Form 483, 2023-09-07
April, 2022 FDA 483 LSNE-Madison, LLC - Form 483, 2022-04-14
June, 2024 FDA 483 MPP Group, LLC - Form 483, 2024-06-07
August, 2024 FDA 483 Bimeda, Inc. - Form 483, 2024-09-20
August, 2021 FDA 483 R.D. Laboratories, Inc. - Form 483, 2021-08-27
December, 2024 FDA 483 ANI Pharmaceuticals, Inc. - Form 483, 2024-12-06
February, 2025 FDA 483 Rebel Converting, LLC - Form 483, 2025-02-24
January, 2025 FDA 483 Alto ICP, LLC - Form 483, 2025-01-30
January, 2023 EIR Nexus Pharmaceuticals, LLC - EIR, 2023-02-15
March, 2025 FDA 483 Noble Pharma, LLC - Form 483, 2025-03-06
May, 2025 FDA 483 Scientific Protein Laboratories LLC - Form 483, 2025-05-02

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more